LIDDS Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from LIDDS
Access all reports
LIDDS AB is a pharmaceutical company, which develops and sells pharmaceutical products for cancer and other diseases in Sweden. It produces various drugs, such as NZ-2HOF to treat prostate cancer; NZ-DTX to treat breast, prostate, head, neck, stomach and lung cancer; NZ-DOX for the treatment of solid tumors; NZ-IO for the treatment of metastatic colorectal cancer; NZ-STING for the treatment of immuno-oncology; and NZ-TLR9 for enhancing cancer immunotherapies. The company has collaboration with PharmIdea SIA to focus on anti-cancer drugs and sterile formulations. LIDDS AB is based in Uppsala, Sweden.
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇸🇪 Sweden